The Antiseptic Needed an Antiseptic: Kits With Recalled ChloraPrep Applicators Get the FDA’s Most Serious Recall Rating
On October 13, 2026, the FDA classified Medline's removal of certain convenience kits containing recalled BD ChloraPrep applicators as a Class I recall. [1] A day later, the agency gave the same classification to a parallel removal by AVID Medical. [2] Class I is the category the FDA reserves for products that could cause serious injury or death.
Hospitals are being told to destroy entire convenience kits, not just the skin-prep applicator inside, over possible fungal contamination in a product whose whole job is keeping microbes out.
Before a surgeon makes an incision or a nurse threads a catheter into a vein, someone swipes the skin with antiseptic. It is one of the most routine acts in medicine, and it exists for one reason: to keep germs out of the body. This week, the Food and Drug Administration attached its most serious recall rating to kits containing skin-prep applicators that may themselves be carrying a fungus.
What was recalled
The problem traces back to two lots made by Becton, Dickinson and Company (BD): ChloraPrep Clear 1 mL Single Sterile applicators (item 930480, lot 4032183) and FREPP Clear 1.5 mL applicators with paper lidding (item 930299, lot 4073005). [1][3] BD announced a nationwide recall of those lots on June 6, 2026, saying that under certain environmental conditions the packaging could allow growth of the fungus Aspergillus penicillioides. [3] BD said the lots shipped between March and June 2024 and that it had received no adverse event reports. [3]
ChloraPrep applicators contain 2% chlorhexidine gluconate and 70% isopropyl alcohol and are used to prepare skin before surgery and catheter placement. [3][4]
Why the whole kit has to go
Hospitals often buy convenience kits that bundle everything needed for a procedure, such as starting an IV, into one sealed package. Medline's first instruction, sent June 12, told customers to pull out the affected applicator, keep using the rest of the kit and add an over-label sticker. [3][5] In August, Medline reversed course for specific items: those kits must now be quarantined and destroyed in full. [3]
AVID Medical made the same switch for an IV start kit containing applicators from BD lot 4032183. [2][3] One detail matters for anyone stocking a supply room: a kit that already carries Medline's earlier sticker is still covered by the destroy order if it appears on the August list. [3] The sticker is not a sign the kit is safe.
The risk
The FDA has said contamination of these applicators could lead to systemic infection, sepsis, illness and death. [1][3] Because the applicator is used right before an invasive procedure, fungus in the packaging can reach the applicator surface or a clinician's gloves and be carried into the sterile field and directly into tissue. [6]
If the fungus reaches the bloodstream during catheter placement, the catheter would likely have to be removed, which means another procedure. A surgical site infection could require treatment that includes long-term antifungal therapy. [3]
What has and hasn't happened
No serious injuries or deaths have been reported in the kit notices. As of August 17, Medline had reported none, and AVID Medical had reported none as of August 6. [3] The recall covers specific lots, not every ChloraPrep product. [3]
This is not BD's first run-in with this fungus. In February 2025, the company recalled a different lot of ChloraPrep Clear 1 mL applicators, lot 3200240, for possible Aspergillus penicillioides contamination. [3][6]
A supply chain that multiplies one mistake
Kit makers buy components from many manufacturers. When a single component lot is recalled, every kit assembler that used it has to trace its own products and notify its own customers. The FDA's device updates log shows a run of 2026 kit notices tied to recalled components, including lidocaine, bupivacaine and sodium chloride ampules. [3][7] One bad lot rarely stays one bad lot.
What readers can do
Facilities. Check stock against the Medline and AVID Medical lists linked from the FDA notices, quarantine affected kits and destroy them after completing the company's response form. Medline's recall line is 866-359-1704. [1][3]
Patients. If you have a procedure coming up, it is reasonable to ask your care team whether recent recall notices have been reviewed. After surgery or catheter placement, contact a clinician about fever, chills, or redness, swelling, drainage or worsening pain at the site. [3]
Everyone. Problems with medical products can be reported to the FDA through MedWatch. [8]
The bottom line
The step designed to stop infection became a possible source of it. No one has been reported harmed, which is the good news. The part worth watching is the timeline: more than four months passed between BD's first recall announcement and the FDA's Class I classification of the kits that carried those applicators.
Vital Biomedical News is reader-supported and accepts no funding from pharmaceutical or medical device companies.
References
U.S. Food and Drug Administration. Convenience Kit Recall: Medline Removes Convenience Kits Affected by BD ChloraPrep Applicator Recall. Updated October 13, 2026. fda.gov
U.S. Food and Drug Administration. Convenience Kit Recall: AVID Medical Removes Convenience Kits Affected by BD ChloraPrep Applicator Recall. Updated October 14, 2026. fda.gov
Brooks D. Hospitals Must Destroy Whole Medline Kits, Not Just Recalled BD ChloraPrep Applicators, in New Class I Recall. Medical Daily. October 15, 2026. medicaldaily.com
Health Canada. BD Canada ChloraPrep product recall; Sterility concerns. June 3, 2026. recalls-rappels.canada.ca
U.S. Food and Drug Administration. Convenience Kit Correction: Medline Issues Correction for Convenience Kits Containing BD ChloraPrep Applicators. fda.gov
RTTNews. BD Recalls ChloraPrep Clear 1 mL Applicators. Nasdaq. 2025. nasdaq.com
U.S. Food and Drug Administration. CDRH New – News and Updates. fda.gov
U.S. Food and Drug Administration. MedWatch: The FDA Safety Information and Adverse Event Reporting Program. fda.gov